Glimepiride-Loaded Nanoemulgel; Development, In Vitro Characterization, Ex Vivo Permeation and In Vivo Antidiabetic Evaluation

Glimepiride (GMP), an oral hypoglycemic agent is extensively employed in the treatment of type 2 diabetes. Transdermal delivery of GMP has been widely investigated as a promising alternative to an oral approach but the delivery of GMP is hindered owing to its low solubility and permeation. The prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Razzaq, Fizza Abdul, Asif, Muhammad, Asghar, Sajid, Iqbal, Muhammad Shahid, Khan, Ikram Ullah, Khan, Salah-Ud-Din, Irfan, Muhammad, Syed, Haroon Khalid, Khames, Ahmed, Mahmood, Hira, Ibrahim, Asim Y., El Sisi, Amani M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467883/
https://www.ncbi.nlm.nih.gov/pubmed/34572054
http://dx.doi.org/10.3390/cells10092404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467883/
https://www.ncbi.nlm.nih.gov/pubmed/34572054
http://dx.doi.org/10.3390/cells10092404

Ejemplares similares